Delivery Order SPE2DB25D3017-SPE2DB25FVKLN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) valued at $2,634.43. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate ER 54 mg tablets in quantities of 100 units, valued at $1,279.09. This competitive award, issued without set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.40 to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Methylphenidate is a central nervous system stimulant commonly used in military and veteran...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for Methylphenidate ER 54 mg tablets (100-count) with a ceiling value of $1,183.83 and an ultimate completion date of September 2, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate Extended-Release 36 mg tablets in quantities of 100 units. This contract, valued at $1,697.25, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $5,992.32 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count packages) with a contract value of $2,196.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,386.06. This firm fixed-price delivery order, which is expected to be completed by July 30, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,239.54 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count supply) on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded without set-aside designation and operates under a firm fixed price contract structure. The performance location is listed as the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.28 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKLNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price arrangement with a ceiling value of $1,297.75. This non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a wide range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency and other government healthcare programs. This delivery order for methylphenidate, a controlled substance commonly used in attention deficit disorder treatment, reflects the company's ongoing role as a key supplier within the DLA's pharmaceutical supply chain supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/2/25 |